JohnRobertStanleyIIIMD

PubMed

• Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering.
  Yoshida K, Ishii K, Shimizu A, Yokouchi M, Amagai M, Shiraishi K, Shirakata Y, Stanley JR, Ishiko A> ;J. Dermatol. Sci.. 2016-12-12
• Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.
  Hammers CM, Stanley JR> ;Annu Rev Pathol. 2016-05-23
• Patients with pemphigus foliaceus may retain antibody reactivity against calcium-stabilized, distal desmoglein 1 domains in remission.
  Hammers CM, Stanley JR> ;Br. J. Dermatol.. 2016-01-01
• Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years.
  Hammers CM, Chen J, Lin C, Kacir S, Siegel DL, Payne AS, Stanley JR> ;J. Invest. Dermatol.. 2015-03-01
• From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases.
  Ludwig RJ, Borradori L, Diaz LA, Hashimoto T, Hertl M, Ibrahim SM, Jonkman MF, Kitajima Y, Murrell DF, Schmidt E, Shimizu H, Stanley JR, Woodley DT, Zillikens D> ;J. Invest. Dermatol.. 2014-09-01
• Antibody phage display: technique and applications.
  Hammers CM, Stanley JR> ;J. Invest. Dermatol.. 2014-02-01
• Targeted delivery of tumor necrosis factor-related apoptosis-inducing ligand to keratinocytes with a pemphigus mAb.
  Kouno M, Lin C, Schechter NM, Siegel D, Yang X, Seykora JT, Stanley JR> ;J. Invest. Dermatol.. 2013-09-01
• Desmoglein-1, differentiation, and disease.
  Hammers CM, Stanley JR> ;J. Clin. Invest.. 2013-04-01
• Autoimmune reactivity against precursor form of desmoglein 1 in healthy Tunisians in the area of endemic pemphigus foliaceus.
  Toumi A, Saleh MA, Yamagami J, Abida O, Kallel M, Masmoudi A, Makni S, Turki H, Hachiya T, Kuroda K, Stanley JR, Masmoudi H, Amagai M> ;J. Dermatol. Sci.. 2013-04-01
• 15 citations
  Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes
  Yongxin Jeremy Yu, Kristian F. Hanssen, V. Kalyanaraman, A. Chirindel, Alicia J. Jenkins, Alison Nankervis, Peter A. Torjesen, Hanne Scholz, Tore Henriksen, Bjørg Lore...> ;BJOG. 2012 Nov 1
• Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients.
  Lunardon L, Tsai KJ, Propert KJ, Fett N, Stanley JR, Werth VP, Tsai DE, Payne AS> ;Arch Dermatol. 2012-09-01
• Plasma Lipoproteins and Preeclampsia in Women with Type 1 Diabetes: A Prospective Study.
  Basu, A., Alaupovic, P., Wu, M., Jenkins, A. J., Yu, Y., Nankervis, A. J., Hanssen, K. F., Scholz, H., Henriksen, T., Lorentzen, B., Clausen, T., Garg, S. K., Menard, ...> ;J Clin Endocrinol Metab. 2012 May
• Desmoglein as a target in skin disease and beyond.
  Amagai M, Stanley JR> ;J. Invest. Dermatol.. 2012-03-01
• Synergy of understanding dermatologic disease and epidermal biology.
  Stanley, J.R.> ;J Clin Invest. 2012 Feb 1
• Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity.
  Yamagami J, Payne AS, Kacir S, Ishii K, Siegel DL, Stanley JR> ;J. Clin. Invest.. 2010-11-01
• Antibodies to the desmoglein 1 precursor proprotein but not to the mature cell surface protein cloned from individuals without pemphigus.
  Yamagami J, Kacir S, Ishii K, Payne AS, Siegel DL, Stanley JR> ;J. Immunol.. 2009-11-01
• Update on the cloning of monoclonal anti-desmoglein antibodies from human pemphigus patients: implications for targeted therapy.
  Stanley JR, Ishii K, Siegel DL, Payne AS> ;Vet. Dermatol.. 2009-10-01
• Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of proseque...
  Yokouchi M, Saleh MA, Kuroda K, Hachiya T, Stanley JR, Amagai M, Ishii K> ;J. Invest. Dermatol.. 2009-09-01
• 48 citations
  Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women.
  Yongxin Yu, Alicia J. Jenkins, Alison Nankervis, Kristian F. Hanssen, Hanne Scholz, Tore Henriksen, Bjorg Lorentzen, Torun Clausen, Satish K. Garg, M. K. Menard, Samar...> ;Diabetologia. 2009 Jan 1
• Autoimmune Bullous Diseases: Historical Perspectives.
  Stanley JR, Amagai M> ;J. Invest. Dermatol.. 2008-10-01
• Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies.
  Ishii, K., Lin, C., Siegel, D.L., Stanley, J.R.> ;J Invest Dermatol. 2008 Apr
• Autoimmune Bullous Diseases: Historical Perspectives.
  Stanley, J.R., Amagai, M.> ;J Invest Dermatol. 2008
• Targeting pemphigus autoantibodies through their heavy-chain variable region genes.
  Payne, A.S., Siegel, D.L., Stanley, J.R.> ;J Invest Dermatol. 2007 Jul
• Milestones in Investigative Dermatology: The Desmosome.
  Kowalczyk AP, Rubenstein DS, Garrod DR, Green KJ, Stanley JR> ;J. Invest. Dermatol.. 2007-01-01
• Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome.
  Stanley, J.R., Amagai, M.> ;N Engl J Med. 2006 Oct 26
• Join now to see all